I'm a little concerned Ngr. I invested a lot for their cancer research and everything else and everything is on the shelf except for their last minute pain patches. The real money is in the cancer research IMO. They have all their eggs in one basket and IF they are halted due to the dea well what's next? How the antibody went from being the best thing since sliced bread to on the shelf concerns me. Where's the resubmission of the patent? The uptick interview was nothing but the patches? What's your opinion?
News 
Market Data 
Discover 
AI
